tiprankstipranks
Trending News
More News >
Glucotrack, Inc. (GCTK)
:GCTK
US Market
Advertisement

GlucoTrack (GCTK) Technical Analysis

Compare
236 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
6Neutral
10Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Glucotrack, Inc.’s (GCTK) Moving Averages Convergence Divergence (MACD) indicator is 0.39, suggesting Glucotrack, Inc. is a Buy.
Glucotrack, Inc.’s (GCTK) 20-Day exponential moving average is 7.06, while Glucotrack, Inc.’s (GCTK) share price is $7.14, making it a Sell.
Glucotrack, Inc.’s (GCTK) 50-Day exponential moving average is 7.09, while Glucotrack, Inc.’s (GCTK) share price is $7.14, making it a Sell.

GlucoTrack (GCTK) Pivot Points

Oct 16, 2025, 12:03 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
6.33
6.63
6.89
7.19
7.45
7.75
8.01
Fibonacci
6.63
6.85
6.98
7.19
7.41
7.54
7.75
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlucoTrack (GCTK) Moving Averages

Oct 16, 2025, 12:03 PM
Period
Simple
Exponential
MA5
7.57Sell
7.38Sell
MA10
7.52Sell
7.35Sell
MA20
6.93Buy
7.06Sell
MA50
6.14Buy
7.09Sell
MA100
6.52Buy
33.86Sell
MA200
30.90Sell
170.19Sell
Glucotrack, Inc.’s (GCTK) 10-Day exponential moving average is 7.35, while Glucotrack, Inc.’s (GCTK) share price is $7.14, making it a Sell.
Glucotrack, Inc.’s (GCTK) 100-Day exponential moving average is 33.86, while Glucotrack, Inc.’s (GCTK) share price is $7.14, making it a Sell.
Glucotrack, Inc.’s (GCTK) stock price is $7.14 and Glucotrack, Inc.’s (GCTK) 50-day simple moving average is 6.14, creating a Buy signal.
Glucotrack, Inc.’s (GCTK) stock price is $7.14 and Glucotrack, Inc.’s (GCTK) 100-day simple moving average is 6.52, creating a Buy signal.
Glucotrack, Inc.’s (GCTK) stock price is $7.14 and Glucotrack, Inc.’s (GCTK) 200-day simple moving average is 30.90, creating a Sell signal.

GlucoTrack (GCTK) Technical Indicators

Oct 16, 2025, 12:03 PM
Name
Value
Implied Action
RSI (14)
51.22
Neutral
STOCH (9,6)
33.99
Neutral
STOCHRSI (14)
45.86
Neutral
MACD (12,26)
0.39
Buy
ADX (14)
35.84
Neutral
Williams %R
-66.62
Buy
CCI (14)
12.53
Neutral
ATR (14)
0.79
-
Ultimate Oscillator
50.65
Neutral
ROC
14.87
Buy
Glucotrack, Inc.’s (GCTK) Relative Strength Index (RSI) is 51.22, creating a Neutral signal.
Glucotrack, Inc.’s (GCTK) Trend Strength Indicator (ADX) is 35.84, creating a Neutral signal.
Glucotrack, Inc.’s (GCTK) Commodity Channel Index (CCI) is 12.53, creating a Neutral signal.
Glucotrack, Inc.’s (GCTK) Price Rate of Change (ROC) is 14.87, creating a Buy signal.

FAQ

Is GCTK a Buy, Hold, or Sell?
Based on GCTK’s technical indicators, GCTK is a Sell.
    What is GCTK’s RSI (14)?
    GCTK’s RSI (14) is 51.22, which suggests GCTK is a Neutral.
      What is GCTK’s MACD?
      GCTK’s MACD is 0.39, which suggests GCTK is a Buy.
        What is GCTK’s 5-day moving average?
        GCTK’s 5-day moving average is 7.57, which suggests GCTK is a Sell.
          What is GCTK’s 20-day moving average?
          GCTK 20-day moving average is 6.93, which suggests GCTK is a Buy.
            What is GCTK’s 50-day moving average?
            GCTK’s 50-day moving average is 6.14, which suggests GCTK is a Buy.
              What is GCTK’s 200-day moving average?
              GCTK’s 200-day moving average is 30.90, which suggests GCTK is a Sell.
                What is GCTK’s Williams % R (14)?
                GCTK’s Williams % R (14) is -66.62, which suggests GCTK is a Buy.
                  What is GCTK’s CCI (14)?
                  GCTK’s CCI (14) is 12.53, which suggests GCTK is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis